News GSK looks to expand reach of key COPD drug Trelegy GlaxoSmithKline and partner Innoviva are seeking an expansion to the US label of their Trelegy Ellipta lung drug.
News AZ to file COPD combo in China and Japan AstraZeneca is planning filings of its chronic obstructive pulmonary disease drug Bevespi Aerosphere in China and Japan, based on a new set of positive phase 3 trial results.
News GSK and Propeller prepare to launch digital inhaler Deal expands to a commercialisation partnership to prepare for US and Europe marketing.
News Kaken details the data behind its PI3K inhibitor filing Kaken has revealed the data that supported its recent marketing application for serabelisib as a treatment for vascular malformations in Japan.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
